Yonhap Infomax NewsKorea Pharmaceutical and Bio-Pharma Manufacturers Association holds emergency meeting to address government's drug price reform, which cuts generic pricing rate from 53.55% to 45%, with gradual implementation until 2036 to minimize industry impact
#YonhapInfomax #DrugPriceReform #KoreaPharmaceuticalAssociation #GenericDrugs #MinistryOfHealthAndWelfare #PricingRate #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=113533
#YonhapInfomax #DrugPriceReform #KoreaPharmaceuticalAssociation #GenericDrugs #MinistryOfHealthAndWelfare #PricingRate #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=113533
Korea Pharmaceutical and Bio-Pharma Manufacturers Association Vows to Minimize Industry Impact from Government Drug Price Cuts
Korea Pharmaceutical and Bio-Pharma Manufacturers Association holds emergency meeting to address government's drug price reform, which cuts generic pricing rate from 53.55% to 45%, with gradual implementation until 2036 to minimize industry impact